4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-25-335481
Chief Legal Officer sold 11,276 shares at $13.15 ($148,244)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sullivan Mark Chief Legal Officer | 2025-12-26 | Sale 10b5-1 | −11,276 | $13.15 | $148,244 | 282,576 | D: show line 1 in the form |
| Open-market sales · 11,276 sh · avg $13.15 · $148,244 | |||||||
Loading xslF345X05/ownership.xml…